Stuttgart beats Heidenheim to climb into Bundesliga top four

STUTTGART, Germany (AP) — Bilal El Khannouss continued his successful start to life on loan at Stuttgart as he scored the only goal of the game in a 1-0 win over Heidenheim in the Bundesliga on Sunday.

In driving rain, El Khannouss ran at the Stuttgart defense and dodged two challenges before scoring with a low shot from the edge of the box in the 65th minute.

A third consecutive Bundesliga win lifted Stuttgart to fourth in the league and Heidenheim was left in the relegation zone.

El Khannouss scored for the second time since the Moroccan attacking midfielder joined Stuttgart on loan from Leicester last month.

Beating Heidenheim meant Stuttgart bounced back from a 2-0 loss at Basel in the Europa League on Thursday.

Hamburger SV recorded its biggest margin of victory in a top-division league game for 12 years as Rayan Philippe scored twice in a 4-0 win over Mainz.

Hamburg, which was promoted back to the Bundesliga for this season after being relegated in 2018, was 2-0 up after 10 minutes against a Mainz team lacking first-choice goalkeeper Robin Zentner following his red card against Borussia Dortmund last week.

It's been a tough start to the season for Mainz, which finished sixth last season to qualify for the Conference League but has only four points from six Bundesliga games last season.

Borussia Moenchengladbach stayed winless with a 0-0 draw at home to Freiburg.

Gladbach shored up its defense after conceding six goals against Eintracht Frankfurt last week, and picked up a point to move from last place in the 18-team league to 17th above Heidenheim. Freiburg is eighth. Gladbach is still searching for a new coach after firing Gerardo Seoane last month.

AP soccer: https://apnews.com/hub/soccer

Mönchengladbach's Luca Netz, right, and Freiburg's Jan-Niklas Beste in action during the Bundesliga soccer match between Borussia Mönchengladbach and SC Freiburg at Stadion im Borussia-Park in Mönchengladbach, Germany, Sunday Oct. 5, 2025. (David Inderlied/dpa via AP)

Hamburger's Jean-Luc Dompé, right, celebrates scoring with Luka Vusskovic during the Bundesliga soccer match between Hamburger SV and FSV Mainz 05 at the Volksparkstadion, Hamburg, Germany, Sunday Oct. 5, 2025. (Marcus Brandt/dpa via AP)

Hamburger's Rayan Philippe, center, celebrates scoring during the Bundesliga soccer match between Hamburger SV and FSV Mainz 05 at the Volksparkstadion, Hamburg, Germany, Sunday Oct. 5, 2025. (Marcus Brandt/dpa via AP)

Stuttgart players celebrate Bilal El Khannouss' goal during the Bundesliga soccer match between VfB Stuttgart and 1. FC Heidenheim at MHPArena, Stuttgart, Germany, Sunday Oct. 5, 2025. (Bernd Weissbrod/dpa via AP)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.